Sleep apnea and commercial driving: DOT certification explained

The Federal Motor Carrier Safety Administration has no binding federal formula for screening commercial drivers for obstructive sleep apnea. Congress told the agency it may implement or enforce sleep-disorder screening, testing, or treatment rules only through a rulemaking. The 2024 Medical Examiner’s Handbook repeats that the FMCSRs contain no OSA screening requirement, no preferred test, and no PAP-compliance number. Many examiners still look at a download the way Medicare looks at PAP: about 4 hours of use on 70 percent of nights. That figure is examiner custom and older advisory language, not a regulation.

Is there a federal DOT sleep apnea screening formula?

No. Section 4.8.3.6 of the January 2024 Medical Examiner’s Handbook is explicit. The FMCSRs do not require medical examiners to screen drivers for OSA, do not tell them when to refer for a sleep study, do not name a preferred diagnostic method, and do not set a compliance metric for treatment. The handbook is guidance. FMCSA’s own Federal Register notice for the 2024 edition states that the handbook does not have the force of law and is not meant to bind the public.

What the handbook does say is clinical, not numerical. Untreated moderate-to-severe OSA can contribute to fatigue and unintended sleep episodes, with deficits in attention, concentration, situational awareness, and memory that can interfere with controlling a commercial motor vehicle. Treated moderate-to-severe OSA does not preclude certification. Those two sentences are the regulatory posture: the condition matters for safety, and treatment can keep a driver in the seat.

Examiners are told to look at the sleep-disorder answers on Form MCSA-5875 and at risk factors they can actually see: a small airway, loud snoring, witnessed apneas, sleepiness during the major wake period, obesity, large neck size, hypertension, cardiovascular disease, stroke, diabetes. FMCSA calls a cluster of those factors a reasonable way to decide whether to recommend a sleep study. It specifically rejects relying on a single criterion. There is no BMI cutoff written into the FMCSRs as a mandatory referral trigger.

What did Congress actually forbid?

Public Law 113-45, signed 15 October 2013 and codified as a note to 49 U.S.C. 31305, says the Secretary of Transportation may implement or enforce a requirement for screening, testing, or treatment of commercial motor vehicle operators for sleep disorders, including obstructive sleep apnea, only if that requirement is adopted through a rulemaking. Requirements already in force before 1 September 2013 were left alone. Informal guidance is not a substitute for a rule.

That statute is why trucking groups pushed back when draft handbook language looked like a de facto apnea rule. In the January 22, 2024 Federal Register notice, FMCSA summarized those comments, including from ATA and OOIDA, and answered them this way: Public Law 113-45 does not apply to the handbook because the handbook offers only guidance and the agency has not adopted OSA screening, testing, or treatment requirements. Because the handbook is not a rulemaking, FMCSA also said it cannot grant commenters’ requests that examiners be required to use specific, objective criteria for screening, treatment, and treatment evaluation.

The agency did try a rule. On 10 March 2016, FMCSA and the Federal Railroad Administration published an advance notice of proposed rulemaking on evaluating safety-sensitive personnel for moderate-to-severe OSA. That notice itself recited Public Law 113-45. On 8 August 2017 the agencies withdrew the ANPRM. They have not issued a notice of proposed rulemaking since. Drivers who hear that “DOT requires a sleep study if your BMI is over X” are hearing a clinic or examiner policy, or an older advisory document, not a current federal regulation.

What does the 2024 handbook tell examiners to do instead?

Use judgment. If multiple risk factors are present and the driver has not been evaluated, the examiner should consider recommending a sleep study. If a prior study was negative or showed only mild OSA, another study is not automatically due unless symptoms or risk factors have changed. OSA is not a condition that requires testing on a fixed schedule. For a driver already treated with CPAP or bilevel PAP for moderate-to-severe OSA, retesting is the treating clinician’s call, based on a return of symptoms or a significant change in risk factors.

The certification questions the handbook actually lists are three: Does the driver report, or does the examiner identify, multiple risk factors or symptoms? Are those symptoms likely to interfere with safe CMV operation? If moderate-to-severe OSA is diagnosed, has treatment been shown to be adequate, effective, safe, and stable? “Adequate, effective, safe, and stable” is not defined as a percentage in the FMCSRs. That is the gap drivers feel at the clinic.

For extra reading, the handbook points examiners to the 21 November 2016 MCSAC and Medical Review Board OSA advisory recommendations. Those recommendations are one source an examiner “could consider.” They are not incorporated by reference into 49 CFR part 391. Section 4.8.3.6 also rescinds the January 2015 FMCSA bulletin on OSA. Older training slides that still quote that bulletin are out of date.

Where did 4 hours on 70 percent of nights come from?

From advisory committees and from payer rules, not from a current FMCSR. In April 2012, FMCSA published proposed MCSAC and Medical Review Board recommendations. Those recommendations defined minimally acceptable PAP compliance as at least 4 hours per day of use on 70 percent of days, and they told drivers that more hours are better, with optimal efficacy often described as 7 or more hours of daily use. The 2016 joint MCSAC/MRB letter that the 2024 handbook still links kept that same adherence idea in circulation. The American Academy of Sleep Medicine’s Sleep and Transportation Safety Awareness Task Force, writing in 2017, noted that “current guidelines” define PAP adherence as at least 4 hours per night on at least 70 percent of nights, and that CMS and some insurers use the same threshold for device reimbursement.

That is why a medical examiner in Ohio can still ask for a 90-day compliance report that looks like a Medicare download. The examiner is applying a widely used clinical custom, often the 2016 advisory recommendations the handbook invites them to consider, plus the documentation they are used to seeing from durable-medical suppliers. It is honest to say many examiners still use 4 hours / 70 percent in practice. It is not honest to say FMCSA requires that number of every driver in the United States.

A sleep clinic that tells every commercial driver “you must hit 4/70 or you will lose your card” is stating its own workflow, or that examiner’s workflow, as if it were federal law. Ask which document they are citing. If the answer is “DOT,” ask them to show the regulation. The 2024 handbook will not have a percentage on that page.

How is a DOT physical different from sleep-clinic treatment?

They answer different questions. A DOT physical, performed by an examiner on the National Registry, is a fitness-to-drive determination under 49 CFR part 391. The examiner’s job is whether you can control a commercial motor vehicle safely during the certification period. Sleep medicine’s job is whether you have a sleep-related breathing disorder, how severe it is, and what treatment is appropriate for your health. Those two files should talk to each other. They are not the same visit.

In this office, sleep testing follows sleep-medicine rules, not FMCSA’s missing formula. An uncomplicated adult at increased risk of moderate-to-severe OSA may be a candidate for a home test. A driver with significant heart or lung disease, opioid use, stroke, or suspected hypoventilation generally needs an in-lab study, because a home test can miss central events and cannot stage sleep. That is the American Academy of Sleep Medicine diagnostic guideline, not a DOT checklist. The study is scored for clinical care. The report can be shared with the examiner. The examiner still decides certification.

CPAP therapy in clinic is titrated to treat obstructive events and symptoms. A good night of PAP is the whole sleep period, not a 4-hour floor. The AASM transportation task force made that point in 2017: greater use, for the full duration of sleep, is expected to do more for sleepiness and daytime function than the reimbursement minimum. A driver who barely clears 4/70 may satisfy an examiner and still be sleepy on I-71. That is a clinical problem, even if the card is current.

The clinic also does not certify drivers. We diagnose and treat sleep apnea, generate the study report and the PAP download, and write a letter that states diagnosis, treatment, residual AHI if we have it, and hours of use. The examiner reads that packet against their own reading of the handbook. Two examiners can look at the same 3.8-hour average and reach different certification periods. That variability is the predictable result of Congress blocking unofficial rules and FMCSA declining to write a replacement rule.

What should you bring to the examiner, and what should you bring here?

To the DOT physical: the MCSA-5875 answers filled in without guessing, a copy of the sleep-study report, a recent PAP compliance report if you are treated, and the name of the treating clinician. If you use an oral appliance rather than PAP, bring the dentist’s titration notes and any follow-up study that shows residual AHI. The 2012 MCSAC/MRB recommendations treated PAP as the preferred therapy; they did not make other treatments illegal. An examiner who has never certified a driver on a mandibular device may still ask more questions. Have the documents.

To this office: say that you hold a commercial credential and that an examiner has asked for a study or a download. That changes scheduling and the letter we write. It does not change how we score the study. We will not invent a “DOT AHI cutoff” that FMCSA itself refused to put in the handbook. If an examiner wants a specific test type or a specific follow-up interval, we need that in writing from the examiner, because it is their certification condition, not a federal protocol we can look up.

Do not stop PAP the week before the physical to “prove you need it,” and do not borrow a relative’s machine for the download. Examiners who read downloads for a living notice serial numbers and usage patterns. The honest packet is the one that matches the machine you actually use on the road.

Does treated sleep apnea keep you off the road?

The handbook’s sentence is the one that matters: if treated, moderate-to-severe OSA does not preclude certification. The safety issue the agency names is untreated disease and the sleepiness that comes with it. AASM’s 2017 transportation comments, written during the ANPRM, argued that moderate-to-severe OSA is common among commercial operators, that it contributes to crash risk, and that CPAP is effective and economically viable. Those are professional recommendations to an agency that later withdrew the rulemaking. They are not a substitute for the FMCSRs.

If you are sleepy at the wheel, that is a safety problem today, card or no card. Pull off. Call the examiner and this office after you are parked. Certification paperwork is slower than a microsleep on State Route 3.

For a sleep evaluation that can be documented for an examiner, call Westerville Sleep Center at (614) 898-9340. Bring the examiner’s request if you have one. We will tell you what the study can show. We will not pretend a clinic custom is a federal rule.